GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,491.00p
   
  • Change Today:
      26.50p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,069.46m
  • Volume: 5,765,639
  • Market Cap: £60,676m
  • RiskGrade: 129
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
15-Aug-25 Buy Hal Barron 2,903.94p 84 £2,439.31
15-Aug-25 Buy Hal Barron 2,903.94p 3,328 £96,655.92

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
15-Aug-25 Buy Hal Barron 2,903.94p 3,328 £96,655.92
15-Aug-25 Buy Hal Barron 2,903.94p 84 £2,439.31

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,474,374 £3,779,302,916
Hal Barron 6,662,591 £99,339,232
Emma Walmsley 3,031,547 £45,200,366
Jonathan Symonds 67,893 £1,012,285
Charles Bancroft 60,991 £909,376
Julie Brown 44,386 £661,795
Anne Beal 7,031 £104,832
Harry (Hal) C. Dietz 5,662 £84,420
Elizabeth (Liz) McKee Anderson 3,946 £58,835
Jeannie Lee 2,592 £38,647
Wendy Becker 2,536 £37,812

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £3,779,149,850
Dodge & Cox 253,464,108 £3,779,149,850
BlackRock Inc 231,975,400 £3,458,753,214
GSK plc 197,068,169 £2,938,286,400
The Capital Group Companies, Inc. 159,068,073 £2,371,704,968
Legal & General Group Plc 95,878,187 £1,429,543,768

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,491.00p
Change Today 26.50p
% Change 1.81 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 5,765,639
Shares Issued 4,069.46m
Market Cap £60,676m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 09-Sep-2025

Time Volume / Share Price
16:15 6 @ 1,489.50p
16:19 2 @ 1,489.00p
16:19 2 @ 1,489.00p
16:14 0 @ 1,491.00p
16:14 0 @ 1,491.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page